Martin Plöderl

20PUBLICATIONS
10CO-AUTHORS
Child and adolescent developmentParticle and high energy physics not elsewhere classifiedPredictive and prognostic markersOccupational epidemiologyClinical neuropsychology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|May 28, 2026
Concerning the harm-benefit ratio of escitalopram for pediatric generalized anxiety disorder. A critical viewpoint on the evidence and approval process.

|Oct 10, 2025
False reassurances based on inadequate data not helpful.

Mark A Horowitz, Michael P Hengartner, Martin Plöderl

|Jun 05, 2024
Dynamic association between suicidal ambivalence and suicide risk among individuals with a history of suicide attempts.

Clemens Fartacek, Reinhold Fartacek, Günter K Schiepek

|Apr 01, 2024
Daylight saving time was not associated with a change in suicide rates in Austria, Switzerland and Sweden.

Martin Plöderl, Eva-Maria Pichler, Joakim Westerlund

|Sep 19, 2023
Re: "A Multicenter Double-Blind, Placebo-Controlled Trial of Escitalopram in Children and Adolescents with Generalized Anxiety Disorder" by Strawn et al.-Concerning Harm-Benefit Ratio in a Recent Trial About Escitalopram for Generalized Anxiety Disorder.

Martin Plöderl, Mark A Horowitz, Michael P Hengartner

|Dec 13, 2022
Evidence does not confirm that lithium prevents suicide: a reply to Bschor et al.

Joanna Moncrieff, Martin Plöderl, Zainab Nabi

Pageof 4

Frequent Collaborators

5 joint publications

Michael Pascal Hengartner

4 joint publications

Joanna Moncrieff

2 joint publications

Clemens Fartacek

2 joint publications

Mark Horowitz